Drugs & TargetsFree FDA approves Janssen’s Darzalex for new multiple myeloma indication September 27, 2019Vol.45 No.36
Drugs & TargetsFree Cologuard gets FDA approval for use in younger patients indication September 27, 2019Vol.45 No.36
Drugs & TargetsFree Astellas gets CHMP nod for Xospata as monotherapy for an AML indication September 27, 2019Vol.45 No.36
Drugs & TargetsFree CHMP recommends approval for Bavencio + Axitinib for first-line treatment of advanced RCC September 27, 2019Vol.45 No.36
Drugs & TargetsFree Celsius Therapeutics brings genomics platform to three institutions worldwide September 27, 2019Vol.45 No.36
Drugs & TargetsFree Foundation Medicine, Natera to advance personalized cancer monitoring September 27, 2019Vol.45 No.36
Drugs & TargetsFree Adaptive Biotechnologies, Amgen use clonoSEQ as preferred MRD test September 27, 2019Vol.45 No.36
Clinical RoundupFree Breast cancer patients who exercise pre-diagnosis are at lower risk for heart disease September 27, 2019Vol.45 No.36
Clinical RoundupFree One in five young adults regularly uses e-cigarettes and believes they are harmless, not addictive September 27, 2019Vol.45 No.36
